182 related articles for article (PubMed ID: 21434974)
1. Denosumab.
Dubois EA; Rissmann R; Cohen AF
Br J Clin Pharmacol; 2011 Jun; 71(6):804-6. PubMed ID: 21434974
[No Abstract] [Full Text] [Related]
2. [Denosumab - a new option in the treatment of osteoporosis].
Franek E
Endokrynol Pol; 2011; 62 Suppl 2():37-41. PubMed ID: 22125021
[TBL] [Abstract][Full Text] [Related]
3. Denosumab for the treatment of osteoporosis.
Iqbal J; Sun L; Zaidi M
Curr Osteoporos Rep; 2010 Dec; 8(4):163-7. PubMed ID: 20857349
[TBL] [Abstract][Full Text] [Related]
4. Denosumab.
Rizzoli R; Yasothan U; Kirkpatrick P
Nat Rev Drug Discov; 2010 Aug; 9(8):591-2. PubMed ID: 20671758
[No Abstract] [Full Text] [Related]
5. Molecule of the Month. Denosumab.
Drug News Perspect; 2009; 22(6):356. PubMed ID: 19771324
[No Abstract] [Full Text] [Related]
6. Treatment of osteoporosis with denosumab.
Lewiecki EM
Maturitas; 2010 Jun; 66(2):182-6. PubMed ID: 20236778
[TBL] [Abstract][Full Text] [Related]
7. Denosumab for bone metastases.
Med Lett Drugs Ther; 2011 Jan; 53(1356):8. PubMed ID: 21252843
[No Abstract] [Full Text] [Related]
8. Denosumab--an emerging treatment for postmenopausal osteoporosis.
Lewiecki EM
Expert Opin Biol Ther; 2010 Mar; 10(3):467-76. PubMed ID: 20095877
[TBL] [Abstract][Full Text] [Related]
9. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.
Dempster DW; Lambing CL; Kostenuik PJ; Grauer A
Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513
[TBL] [Abstract][Full Text] [Related]
10. [The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis].
Varenna M; Gatti D
Reumatismo; 2010; 62(3):163-71. PubMed ID: 21052563
[TBL] [Abstract][Full Text] [Related]
11. Denosumab in men receiving androgen-deprivation therapy for prostate cancer.
Smith MR; Egerdie B; Hernández Toriz N; Feldman R; Tammela TL; Saad F; Heracek J; Szwedowski M; Ke C; Kupic A; Leder BZ; Goessl C;
N Engl J Med; 2009 Aug; 361(8):745-55. PubMed ID: 19671656
[TBL] [Abstract][Full Text] [Related]
12. Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
Cummings SR; San Martin J; McClung MR; Siris ES; Eastell R; Reid IR; Delmas P; Zoog HB; Austin M; Wang A; Kutilek S; Adami S; Zanchetta J; Libanati C; Siddhanti S; Christiansen C;
N Engl J Med; 2009 Aug; 361(8):756-65. PubMed ID: 19671655
[TBL] [Abstract][Full Text] [Related]
13. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
[TBL] [Abstract][Full Text] [Related]
14. Effect of RANKL-specific denosumab on osteoclast number and function: a potential friend or foe?
Tankó LB
Curr Opin Investig Drugs; 2007 Oct; 8(10):830-5. PubMed ID: 17907059
[TBL] [Abstract][Full Text] [Related]
15. Denosumab and bisphosphonates: different mechanisms of action and effects.
Baron R; Ferrari S; Russell RG
Bone; 2011 Apr; 48(4):677-92. PubMed ID: 21145999
[TBL] [Abstract][Full Text] [Related]
16. Denosumab: a review of its use in the treatment of postmenopausal osteoporosis.
Moen MD; Keam SJ
Drugs Aging; 2011 Jan; 28(1):63-82. PubMed ID: 21174488
[TBL] [Abstract][Full Text] [Related]
17. Denosumab--a new option in the treatment of osteoporosis.
Franek E
Endokrynol Pol; 2011; 62(1):79-83. PubMed ID: 21365584
[TBL] [Abstract][Full Text] [Related]
18. An antibody against RANKL for the treatment of osteoporosis, inflammatory and malignant bone diseases.
Maldonado-Gonzales E; Pietschmann P
Wien Med Wochenschr; 2010 Sep; 160(17-18):458-63. PubMed ID: 20714812
[TBL] [Abstract][Full Text] [Related]
19. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
Wensel TM; Iranikhah MM; Wilborn TW
Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
[TBL] [Abstract][Full Text] [Related]
20. Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
Geusens P
Clin Interv Aging; 2009; 4():241-50. PubMed ID: 19554095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
